surpass 1 tirzepatide Read now: The SURPASS-EARLY trial found that starting #tirzepatide early in #type2diabetes led to greater improvements in blood sugar, body weight, and waist size than intensified standard care. https://bit.ly/3RWnB8m Body weight loss with tirzepatide

A generic version of Victoza became available in December 2024

Sustained-release GLP-1 receptor agonists (GLP-1RAs) are a type of medication that slowly releases GLP-1RA into the bloodstream over time, which allows for longer-lasting effects and less frequent injections compared to traditional GLP-1RAs

Medication Options That Fit Your Preference Compounded Semaglutide and Tirzepatide are available at accessible price points

Plus, our weight loss service includes weight loss support and a patient account where you can contact a doctor for free with any follow-up questions

Because the drug remains in the body for an extended period, patients do not need to remember daily injections, reducing the treatment burden associated with diabetes management